Personalising Treatment for Myeloma Patients Based on Initial Response to NHS Treatment and Their Overall Fitness Level
Personalising Treatment for Myeloma Patients Based on Initial Response to NHS Treatment and Their Overall Fitness Level
Recruiting · NCT07649525 · Registry updated 2026-07-15Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Personalising Treatment for Myeloma Patients Based on Initial Response to NHS Treatment and Their Overall Fitness Level | Blood Protein Disorders, Frailty, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Pathologic Processes, Pathological Conditions, Signs and Symptoms, cardiovascular disorder, hematologic disorder, hemorrhagic disease, immune system disorder, immunoproliferative disorder, leukemia, lymphoproliferative syndrome, monoclonal gammopathy, neoplasm, plasma cell leukemia, plasma cell neoplasm, vascular disorder, vascular hemostatic disease | Recruiting | Phase 3 | 2026-07-15 | NCT07649525 |
4 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Blood Cancer UK | 1 |
| Cancer Research UK | 59 |
| Johnson & Johnson | 34 |
| University of Leeds | 70 |
5 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Bristol Haematology and Oncology Centre | Bristol | United Kingdom | 26 |
| Eastbourne District General Hospital | Eastbourne | United Kingdom | 4 |
| St James University Hospital | Leeds | United Kingdom | 20 |
| The Clatterbridge Cancer Centre - Liverpool | Liverpool | United Kingdom | 2 |
| The Royal Marsden Hospital | London | United Kingdom | 2 |